The Pivotal Study of RapidPulseTM Aspiration System (NCT06029491)
The Pivotal Study of RapidPulseTM Aspiration System as Frontline Approach for Patient With Acute Ischemic Stroke Due to Large Vessel Occlusions
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or last seen normal. Subjects will undergo mechanical thrombectomy (a procedure to remove a clot in the brain which is preventing blood flow), with the RapidPulseTM Aspiration System. Participation in the trial is for 90 days.
Who can join: Review the eligibility criteria below.
Location: Providence Saint John's Medical Foundation — Torrance, California
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (30 Sites)
Showing the first 25 of 30 sites.
- Providence Saint John's Medical Foundation — Torrance, California
- Yale University — New Haven, Connecticut
- Baptist Health Research Institute — Jacksonville, Florida
- University of South Florida — Tampa, Florida
- Emory University at Grady — Atlanta, Georgia
- Rush University Medical Center — Chicago, Illinois
- Advocate Aurora Research Institute — Park Ridge, Illinois
- Indiana University Health — Indianapolis, Indiana
- State University of Iowa — Iowa City, Iowa
- Washington University — St Louis, Missouri
- Cooper Health System — Camden, New Jersey
- State University of New York at Buffalo — Buffalo, New York
- Icahn School of Medicine at Mount Sinai — New York, New York
- UPMC — Pittsburgh, Pennsylvania
- Prisma Health — Greenville, South Carolina
- Semmes Murphey Foundation - Baptist Memorial Hospital — Memphis, Tennessee
- Vanderbilt University Medical Center — Nashville, Tennessee
- Valley Baptist Medical Center - Harlingen — Harlingen, Texas
- Centre Hospitalier Universitaire de Bordeaux — Bordeaux,
- Centre Hospitalier Universitaire de Montpellier — Montpellier,
- Centre Hospitalier Universitaire de Toulouse — Toulouse,
- Hospital General Universitario Dr. Balmis — Alicante,
- Hospital Universitari Germans Trias i Pujol — Badalona,
- Hospital Universitari Vall d' Hebron — Barcelona,
- Hospital Universitari de Bellvitge — Barcelona,
📞 Contact the Study Coordinator
Phone: (949) 836-7402
Email: cyang@rapidpulsemed.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Acute Ischemic Stroke
- EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) — Little Rock, Arkansas
- PET Perfusion Imaging Techniques and Comparing Them to CT Perfusion Imaging in Stroke — Edmonton, Alberta
- An EFS to Evaluate the CGuard Prime™ Carotid Stent in Acute Ischemic Stroke — Buffalo, New York
- Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose — Houston, Texas
- Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke — Richmond, British Columbia
- Quelling of Excitotoxicity in Acute Stroke With Ketamine — Wynnewood, Pennsylvania
Explore by condition: All Acute Ischemic Stroke clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.